Press Releases
Eisai presents Non-Clinical Research Findings in 107th Annual Meeting of American Association for Cancer Research
Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated World pharma today/Press releases /-Eisai Co Ltd. announced...
Press Releases
Baxter Receives Marketing Authorization of Nutrition for Preterm Newborns in UK and Denmark
Baxter International Inc announced it has received Marketing Authorization from the Competent Authorities in the United Kingdom and Denmark for NUMETA G13E 300 mL,...
News
Sanofi Invests €300 Million in its Biologics Site in Belgium
Sanofi announced a €300 million investment to expand its site in Geel, Belgium. The investment furthers Sanofi’s commitment to driving the future of biologics...
News
Genentech to Present New Data at AAN Showing Superior Efficacy of Investigational Medicine
Genentech, a member of the Roche group announced that new data from three Phase III studies of the investigational medicine OCREVUS™ (ocrelizumab) will...
Industry Reports
Johnson & Johnson Reports 2016 First-Quarter Results
Johnson & Johnson announced sales of $17.5 billion for the first quarter of 2016, an increase of 0.6% as compared to the first quarter...
Drug Research
Boehringer Ingelheim and Eli Lilly company plans to conduct Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
New studies will evaluate the effect of JARDIANCE for the treatment of chronic heart failure There are approximately 26 million people worldwide,...
Drug Research
Baxter announced the launch of a ready-to-use VANCOMYCIN Injection in sodium chloride for US
Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World pharma today/Press releases /-Advancing Baxter’s longstanding commitment to provide...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read